Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001090 |
---|---|
Receipt number | R000001119 |
Scientific Title | Randomized Phase III Study of Adjuvant Endocrine-Therapy with or without Chemotherapy for Postmenopausal Breast Cancer Patients who Responded to Neoadjuvant Letrozole |
Date of disclosure of the study information | 2008/03/20 |
Last modified on | 2023/11/27 13:08:20 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/03/19 19:37:12 | ||
2 | Update | 2008/12/15 21:32:20 | ||
3 | Update | 2008/12/15 21:32:43 | Anticipated trial start date Last follow-up date |
|
4 | Update | 2009/09/01 15:03:58 | Recruitment status |
|
5 | Update | 2010/05/11 10:58:36 | Address |
|
6 | Update | 2010/11/01 11:17:56 | UMIN ID1 |
|
7 | Update | 2010/11/01 11:25:58 | Email |
|
8 | Update | 2010/12/20 10:12:54 | Genomic information |
|
9 | Update | 2010/12/24 14:37:55 | Key inclusion criteria Key inclusion criteria |
|
10 | Update | 2011/06/28 10:02:32 | Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Name of person sending information Name of person sending information Organization Organization Division name Division name Address TEL Institute Institute Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
11 | Update | 2011/06/28 11:58:49 | Address Address |
|
12 | Update | 2011/09/05 09:59:20 | Organization |
|
13 | Update | 2012/09/10 11:06:40 | Target sample size |
|
14 | Update | 2012/09/10 11:07:57 | Last name of contact person Last name of contact person |
|
15 | Update | 2012/09/10 11:32:46 | Name of person sending information Name of person sending information |
|
16 | Update | 2013/05/31 13:49:17 | Organization Organization Organization |
|
17 | Update | 2013/06/13 14:22:47 | Recruitment status |
|
18 | Update | 2013/06/17 09:20:41 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
19 | Update | 2013/06/17 09:21:31 | Anticipated trial start date Last follow-up date |
|
20 | Update | 2013/06/18 11:43:17 | Anticipated trial start date Last follow-up date |
|
21 | Update | 2016/02/19 14:45:58 | TEL Division name Division name |
|
22 | Update | 2017/08/22 13:50:10 | Name of primary person or sponsor Organization Institutions |
|
23 | Update | 2018/10/12 13:35:22 | Public title |
|
24 | Update | 2023/11/27 13:08:20 | UMIN ID2 |